AlphaCore Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.2M | Buy |
28,029
+4,182
| +18% | +$776K | 0.2% | 100 |
|
|
2025
Q1 | $5M | Buy |
23,847
+4,338
| +22% | +$909K | 0.42% | 47 |
|
|
2024
Q4 | $3.47M | Buy |
19,509
+182
| +0.9% | +$32.3K | 0.75% | 22 |
|
|
2024
Q3 | $3.82M | Buy |
19,327
+42
| +0.2% | +$8.29K | 0.86% | 19 |
|
|
2024
Q2 | $3.31M | Sell |
19,285
-385
| -2% | -$66K | 0.8% | 22 |
|
|
2024
Q1 | $3.58M | Buy |
19,670
+3
| +0% | +$546 | 0.95% | 20 |
|
|
2023
Q4 | $3.05M | Buy |
19,667
+662
| +3% | +$103K | 0.45% | 42 |
|
|
2023
Q3 | $2.83M | Buy |
19,005
+306
| +2% | +$45.6K | 0.45% | 43 |
|
|
2023
Q2 | $2.52M | Buy |
+18,699
| New | +$2.52M | 0.4% | 53 |
|
|
2020
Q2 | – | Sell |
-149
| Closed | -$11K | – | 71 |
|
|
2020
Q1 | $11K | Buy |
+149
| New | +$11K | 0.01% | 201 |
|